Literatur
Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 363: 419–427
Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288: 321–333
Grodstein F, et al. (1997) Postmenopausal hormone therapy and mortality. N Engl J Med 336: 1769–1776.
Gruber Ch, Tschugguel W, Schneeberger Ch, Huber JC (2002) Production and action of estrogens. N Engl J Med 346: 340–352.
Gruber DM, Sator MO, Huber JC (1997) Hormone replacement therapy and breast cancer. Lancet 350: 1628
HABITS (hormonal replacement therapy after breast cancer — is it safe?), a randomised comparison: trial stopped. Lancet 363 (9407): 453–455 (2004)
Phytoöstrogene — eine Alternative zur HRT. Ärztezeitung (2004)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huber, J.C. Wie gefährlich ist die Hormonersatztherapie (HRT) in der Menopause?. Wien Klin Wochenschr 116, 155–158 (2004). https://doi.org/10.1007/BF03040481
Issue Date:
DOI: https://doi.org/10.1007/BF03040481